Omnicell (OMCL) Common Equity (2010 - 2026)

Omnicell (OMCL) has 17 years of Common Equity data on file, last reported at $1.3 billion in Q1 2026.

• On a quarterly basis, Common Equity changed 0.04% year-over-year to $1.3 billion in Q1 2026; TTM through Mar 2026 was $1.3 billion, a 0.04% change from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 0.92% from the prior year.
• Common Equity for Q1 2026 stood at $1.3 billion, up from $1.2 billion in the prior quarter.
• Over the last five years, Common Equity for OMCL reached as high as $1.3 billion in Q2 2025 and fell as low as $1.1 billion in Q1 2022.
• Historically, Common Equity has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2023.
• Across the five-year window, Common Equity dropped 1.44% in 2022 and increased 6.49% in 2023, its largest moves.
• Year by year, Common Equity stood at $1.1 billion in 2022, then increased by 5.2% to $1.2 billion in 2023, then advanced by 4.57% to $1.2 billion in 2024, then fell by 0.92% to $1.2 billion in 2025, then increased by 2.01% to $1.3 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $1.3 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.